← Back to Ennoble
Emerging BME Innovations
EMRAST: Revolutionizing Alzheimer's Early Detection Through Olfactory Biomarkers
An NIH-funded multimodal diagnostic platform combining psychophysical olfactory assessment and ML-based classification to detect pre-clinical Alzheimer's disease years before cognitive symptoms appear.
Jan 15, 20248 min readVamsi Reddy
Read the full piece
This piece is published in full on the Ennoble channel — Vamsi Reddy's platform for long-form perspectives on MedTech, regulatory strategy and biomedical innovation.
View on ORCID →Continue reading